Registration Dossier
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 203-965-8 | CAS number: 112-38-9
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Endpoint summary
Administrative data
Link to relevant study record(s)
Description of key information
Key value for chemical safety assessment
Additional information
Available data on absorption, distribution, metabolism and excretion is very scarce, both for human and experimental animals. Therefore, an assessment of the toxicokinetic behavior of undecylenic acid solely relays on the read-across approach by drawing conclusion on the expected toxicokinetic behavior of undecyclenic acid from the toxicokinetic behavior of similar medium chain length fatty acids if such data exist.
Due to its low water solubility, undecylenic acid, absorption after oral exposure may not be high. A quantitative estimation is difficult, however, in that the role of gastrointestinal uptake mechanism for fatty acids may also work for undecyclenic acid, which in turn could markedly influence its oral bioavailability. Data on dermal absorption (i.e. dermal penetration) are not available and therefore estimates on systemic availability of undecyclenic acid after dermal exposure are currently not possible.
Undecylenic acid should be degradable within the available fatty acid metabolism system. Initial metabolic activation of undecylenic acid may involve several enzymatic systems. First, the double bond at carbon 10 of undecylenic acid may undergo epoxidation followed by further oxidation to yield aldehyde and eventually carboxylic acid intermediates or by hydrolysis to yield diol intermediates. These enzymatic activations to the respective intermediates are expected to be very similar to those that result in the activation of eicosatetraenoic acid to intermediate precursors of leukotriene biosynthesis (Capdevila et al., 1982). Secondly, the cytochrome P450 gene 4 family (CYP4) consists of a group of over 63 members that omega-hydroxylate the terminal carbon of fatty acids (Hardwick, 2008). In mammals, six subfamilies have been identified and three of these subfamily members show a preference in the metabolism of short (C7-C10)-CYP4B, medium (C10-C16)-CYP4A, and long (C16-C26)-CYP4F, saturated, unsaturated and branched chain fatty acids. These omega-hydroxylated fatty acids are converted to dicarboxylic acids, which are preferentially metabolized by the peroxisome beta-oxidation system to shorter chain fatty acids that are transported to the mitochondria for complete oxidation. Third, undecylenic acid may undergo beta-oxidation, the first step of metabolic activation in the chain shortening and turn over process of all fatty acids in the fatty acid cycle (Katz and Guest, 1994).
Several metabolic intermediates of undecylenic acid may react with coenzyme A (CoA) and then enter as the coenzyme A ester the fatty acid pathway and the tricarboxylic acid cycle. To a minor extent, aldehyde intermediates also may be reduced to alcohols or conjugated with labile sulfhydryl-containing substances, such as glutathione (Brabec, 1993).
Plasma concentrations and plasma half-lives of undecylenic acid and its possibly many intermediates may be difficult to measure since many low molecular weight fatty acid derived aldehydes and carboxylic acids (e.g., propionic acid) are endogenous, at least in humans (Lington and Bevan, 1994). Similarly, for the same reasons, excretion rates, both urinary and fecal, will be difficult to establish.
References
Brabec MJ. (1993)Patty’s Hygenie Toxicology, 4thEd.,, Vol. IIA, pages 283 – 327.
Capdevila J, Marnett LJ, Chacos N, Prough RA, Estabrook RW. (1982) Proc. Natl. Acad. Sci. USA.,79, 767-70.
Hardwick JP. (2008) Biochem Pharmacol. 75, 2263-2275.
Katz GV, and Guest D. (1994) Patty’s Hygenie Toxicology, 4thEd., Vol IID, Chapt. 36, pages 3523 – 3671.
Lington AW, and Bevan C. (1994) Patty’s Hygenie Toxicology, 4thEd., Vol. IID, Chapt. 30, pages 2585 – 2750.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.

Route: .live1